Back to search

Aristotle University Of Thessaloniki (AUTH)

Διερεύνηση του ρόλου των T-bet+ Β λεμφοκυττάρων στην παθογένεια του συστηματικού ερυθηματώδη λύκου

Abstract

dc:description

Aim. T-bet+ B cells, known as age-associated B cells (ABCs) and/or double-negative B cells (DN), expand in various autoimmune diseases. This study aimed to clarify whether these populations of B cells serve as prognostic and/or therapeutic tools for human systemic lupus erythematosus (SLE). Methods. Peripheral blood from 22 active SLE patients and 10 healthy donors (HDs) was analyzed. Flow cytometry was used to enumerate T-bet+ B cells, as well as the subsets of ABCs (CD19+CD21–CD11c+T-bet+) and DN (CD19+IgD–CD27–CXCR5–T-bet+). All patients met the 2019 EULAR/ACR classification criteria for SLE. In addition to flow cytometry experiments, 24 hour-long whole blood assay cultures combined with in vitro pharmacological treatments of 1 hour were performed, so as to evaluate the effects of hydroxychloroquine, anifrolumab and fasudil (a Rho-associated protein kinase inhibitor) on the percentages of T-bet+ B cells. Moreover, data from previously published single-cell RNA sequencing (scRNA-seq) studies, regarding 6 HDs and 11 active SLE patients, were used for a meta-analysis focusing on T-bet+ B cells, so as to allow characterization of the genes and pathways associated with the biology of ABCs/DN. Bioinformatics analysis was used to predict the effects of the aforementioned 3 pharmaceutical agents on the percentages of T-bet+ B cells. Results. T-bet+ B cells, as well as ABCs and DN, were expanded in SLE patients. Interestingly, percentages of T-bet+ B cells and DN B cells positively correlated with the SLEDAI score of the patients. Cell culture experiments conducted, confirmed that all 3 compounds examined can deplete T-bet+ B cells, while leaving unaffected the total numbers of lymphocytes, T cells and B cells, respectively. According to scRNA-seq analysis, T-bet was highly expressed in 2 specific B cell clusters with pathogenic characteristics for SLE (atypical memory B cells and activated naïve B cells). The analysis, furthermore, suggested that all three drugs of interest can target T-bet+ B cells. Conclusion. T-bet+ B cells expand in SLE patients and associate with disease activity, thus can probably serve as an additional disease activity and severity biomarker. Circumstantial data suggest that these cells may promote disease pathogenesis and may represent a therapeutic target.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Sachinidis, Athanasios
  • Σαχινίδης, Αθανάσιος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58841

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sachinidis, Athanasios; Σαχινίδης, Αθανάσιος. Διερεύνηση του ρόλου των T-bet+ Β λεμφοκυττάρων στην παθογένεια του συστηματικού ερυθηματώδη λύκου. Aristotle University Of Thessaloniki (AUTH), 2025. http://hdl.handle.net/10442/hedi/58841